Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.31 |
| ▸ | GRM8 | O00222 | 1/20 | 0.31 |
| ▸ | GRM6 | O15303 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.31 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1079794 | 1.00 | GABRR1 (0.32) | GABRR1LMNASLC22A6LDHASRR | |
| SCHEMBL1079802 | 0.94 | GABRR1 (0.33) | GABRR1LMNASLC22A6LTA4HGRIK1 | |
| SCHEMBL1079791 | 0.90 | LDHA (0.31) | LDHASRRGRIK1GRIK2GRM8 | |
| SCHEMBL6536381 | 0.86 | LTA4H (0.30) | LTA4H | |
| SCHEMBL6536383 | 0.86 | LTA4H (0.30) | LTA4H | |
| SCHEMBL9049846 | 0.85 | GRIK1 (0.37) | GABRR1LMNASLC22A6GRIK1GRIK2 | |
| SCHEMBL1674752 | 0.85 | GABRR1 (0.33) | GABRR1LMNASLC22A6GRIK1GRIK2 | |
| SCHEMBL1653844 | 0.84 | SLC22A6 (0.39) | GABRR1LMNASLC22A6LTA4HGRIK1 | |
| SCHEMBL9115301 | 0.83 | GABRR1 (0.37) | GABRR1LMNASLC22A6GRIK1GRIK2 | |
| Hydrochloric Acid SCHEMBL11804611 | 0.82 | SLC22A6 (0.38) | GABRR1LMNASLC22A6GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060093720-A1 | Pumpable, semi-solid low calorie sugar substitute compositions | TATZ ED | 2006-05-04 | — | — | US | claimed |
| EP-0043616-B1 | EDIBLE, PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR MAKING THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 1985-09-11 | — | — | EP | claimed |
| US-4382924-A | VITAMIN AND PHARMACEUTICAL CARRIERS COMPRISING A VEGETABLE OIL, SWEETENER, AND FLAVORANT | THE PROCTER & GAMBLE COMPANY (US) | 1983-05-10 | — | — | US | claimed |
| EP-0043616-A2 | Edible, pharmaceutical compositions and processes for making thereof | THE PROCTER & GAMBLE COMPANY (US) | 1982-01-13 | — | — | EP | claimed |
| US-20240139216-A1 | STABLE ORAL CANNABIDIOL COMPOSITIONS | CARDIOL THERAPEUTICS INC. (CA) | 2024-05-02 | — | — | US | disclosed |
| EP-4255494-A1 | STABLE ORAL CANNABIDIOL COMPOSITIONS | Cardiol Therapeutics Inc. (CA) | 2023-10-11 | — | — | EP | disclosed |
| US-20230256096-A1 | STABILIZING AGENT FOR PROBIOTIC COMPOSITION | OMYA INTERNATIONAL AG (CH) | 2023-08-17 | — | — | US | disclosed |
| EP-4181866-A1 | STABILIZING AGENT FOR PROBIOTIC COMPOSITION | Omya International AG (CH) | 2023-05-24 | — | — | EP | disclosed |
| CN-115803001-A | Stabilizing agent for probiotic compositions | OMYA国际股份公司 | 2023-03-14 | — | — | CN | disclosed |
| EP-4028059-A1 | STABLE MEDICINAL CANNABIDIOL COMPOSITIONS | Cardiol Therapeutics Inc. (CA) | 2022-07-20 | — | — | EP | disclosed |
| WO-2022120457-A1 | STABLE ORAL CANNABIDIOL COMPOSITIONS | CARDIOL THERAPEUTICS INC. (CA) | 2022-06-16 | — | — | WO | disclosed |
| WO-2021046628-A1 | STABLE MEDICINAL CANNABIDIOL COMPOSITIONS | CARDIOL THERAPEUTICS INC. (CA) | 2021-03-18 | — | — | WO | disclosed |
| US-4797300-A | SHORTENINGS, SUCROSE POLYESTER, TRIGLYCERIDE | THE PROCTER & GAMBLE COMPANY (US) | 1989-01-10 | — | — | US | disclosed |
| US-4789664-A | SUCROSE POLYESTERS AND VEGETABLE PROTEINS | THE PROCTER & GAMBLE COMPANY (US) | 1988-12-06 | — | — | US | disclosed |
| EP-0291106-A2 | Compositions containing novel solid, nondigestible, fat-like compounds | THE PROCTER & GAMBLE COMPANY (US) | 1988-11-17 | — | — | EP | disclosed |
| EP-0290216-A2 | Polyol fatty acid polyesters for treating duodenal ulcers | THE PROCTER & GAMBLE COMPANY (US) | 1988-11-09 | — | — | EP | disclosed |
| EP-0271963-A2 | Food compositions with superior blood cholesterol lowering properties | THE PROCTER & GAMBLE COMPANY (US) | 1988-06-22 | — | — | EP | disclosed |
| EP-0043616-B1 | EDIBLE, PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR MAKING THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4382924-A | VITAMIN AND PHARMACEUTICAL CARRIERS COMPRISING A VEGETABLE OIL, SWEETENER, AND FLAVORANT | THE PROCTER & GAMBLE COMPANY (US) | 1983-05-10 | — | — | US | disclosed |
| EP-0043616-A2 | Edible, pharmaceutical compositions and processes for making thereof | THE PROCTER & GAMBLE COMPANY (US) | 1982-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139216-A1 | STABLE ORAL CANNABIDIOL COMPOSITIONS | TTPA, SCD, ECH1 | GABRR1 3011/4885LMNA 1754/4885SLC22A6 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.